NOVO.B.DK

248.05

+0.1%↑

GMAB.DK

1,772.5

+2.4%↑

HLUNB.DK

43.22

+0.32%↑

ZEAL.DK

305.8

+1.46%↑

AMBUB.DK

68.1

-2.08%↓

NOVO.B.DK

248.05

+0.1%↑

GMAB.DK

1,772.5

+2.4%↑

HLUNB.DK

43.22

+0.32%↑

ZEAL.DK

305.8

+1.46%↑

AMBUB.DK

68.1

-2.08%↓

NOVO.B.DK

248.05

+0.1%↑

GMAB.DK

1,772.5

+2.4%↑

HLUNB.DK

43.22

+0.32%↑

ZEAL.DK

305.8

+1.46%↑

AMBUB.DK

68.1

-2.08%↓

NOVO.B.DK

248.05

+0.1%↑

GMAB.DK

1,772.5

+2.4%↑

HLUNB.DK

43.22

+0.32%↑

ZEAL.DK

305.8

+1.46%↑

AMBUB.DK

68.1

-2.08%↓

NOVO.B.DK

248.05

+0.1%↑

GMAB.DK

1,772.5

+2.4%↑

HLUNB.DK

43.22

+0.32%↑

ZEAL.DK

305.8

+1.46%↑

AMBUB.DK

68.1

-2.08%↓

Search

Coloplast A-S (Class B)

Închisă

421.1 -1.89

Rezumat

Modificarea prețului

24h

Curent

Minim

419.3

Maxim

429.2

Indicatori cheie

By Trading Economics

Venit

522M

1.4B

Vânzări

83M

7B

P/E

Medie Sector

24.492

60.328

EPS

6.32

Randament dividend

5.28

Marjă de profit

19.835

Angajați

16,983

EBITDA

309M

2.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

5.28%

2.24%

Următoarele câștiguri

12 mai 2026

Data viitoare de dividende

20 mai 2026

Următoarea dată ex-dividende

18 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-21B

98B

Deschiderea anterioară

422.99

Închiderea anterioară

421.1

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 apr. 2026, 00:00 UTC

Evenimente importante

Australian Flash PMI Bounce in April Conceals Deeper Worries

22 apr. 2026, 23:33 UTC

Câștiguri

SK Hynix Posts Record Quarterly Results Amid AI Boom

22 apr. 2026, 22:40 UTC

Câștiguri

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22 apr. 2026, 22:10 UTC

Achiziții, Fuziuni, Preluări

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22 apr. 2026, 21:11 UTC

Câștiguri

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22 apr. 2026, 21:01 UTC

Câștiguri

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22 apr. 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

22 apr. 2026, 23:46 UTC

Market Talk

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22 apr. 2026, 23:34 UTC

Market Talk
Evenimente importante

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22 apr. 2026, 23:16 UTC

Câștiguri

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22 apr. 2026, 23:15 UTC

Câștiguri

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22 apr. 2026, 22:54 UTC

Câștiguri

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22 apr. 2026, 22:54 UTC

Câștiguri

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22 apr. 2026, 22:52 UTC

Câștiguri

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22 apr. 2026, 22:51 UTC

Câștiguri

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22 apr. 2026, 22:31 UTC

Câștiguri

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22 apr. 2026, 22:31 UTC

Câștiguri

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22 apr. 2026, 22:30 UTC

Câștiguri

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22 apr. 2026, 22:30 UTC

Câștiguri

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22 apr. 2026, 22:29 UTC

Câștiguri

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22 apr. 2026, 22:28 UTC

Câștiguri

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22 apr. 2026, 22:28 UTC

Câștiguri

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22 apr. 2026, 22:27 UTC

Câștiguri

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22 apr. 2026, 22:06 UTC

Market Talk
Câștiguri

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22 apr. 2026, 21:55 UTC

Achiziții, Fuziuni, Preluări

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22 apr. 2026, 21:47 UTC

Câștiguri

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 apr. 2026, 21:37 UTC

Câștiguri

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22 apr. 2026, 21:34 UTC

Câștiguri

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22 apr. 2026, 21:29 UTC

Câștiguri

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 apr. 2026, 21:20 UTC

Market Talk
Câștiguri

Tesla Expands Manufacturing to Chips -- Market Talk

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat